Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 34% ± 10% | |
glutamatergic neuron | 5 studies | 36% ± 18% | |
GABAergic neuron | 4 studies | 34% ± 14% | |
epithelial cell | 4 studies | 19% ± 4% | |
astrocyte | 4 studies | 22% ± 3% | |
microglial cell | 3 studies | 16% ± 1% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 4% | |
club cell | 3 studies | 21% ± 1% | |
transit amplifying cell | 3 studies | 26% ± 10% | |
interneuron | 3 studies | 31% ± 18% | |
neuron | 3 studies | 35% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 30% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2315.30 | 459 / 459 | 100% | 31.45 | 1118 / 1118 |
esophagus | 100% | 2418.53 | 1445 / 1445 | 100% | 43.58 | 183 / 183 |
ovary | 100% | 1873.02 | 180 / 180 | 100% | 26.41 | 430 / 430 |
lung | 100% | 2108.76 | 578 / 578 | 100% | 27.73 | 1153 / 1155 |
intestine | 100% | 1991.52 | 966 / 966 | 100% | 29.32 | 526 / 527 |
skin | 100% | 3434.03 | 1809 / 1809 | 100% | 43.61 | 471 / 472 |
uterus | 100% | 2303.02 | 170 / 170 | 100% | 27.42 | 458 / 459 |
stomach | 100% | 1949.42 | 359 / 359 | 100% | 29.31 | 285 / 286 |
bladder | 100% | 2570.62 | 21 / 21 | 100% | 26.18 | 502 / 504 |
thymus | 100% | 2882.25 | 653 / 653 | 100% | 19.59 | 602 / 605 |
pancreas | 100% | 2365.58 | 328 / 328 | 99% | 16.65 | 177 / 178 |
prostate | 100% | 2446.26 | 245 / 245 | 99% | 19.81 | 499 / 502 |
brain | 99% | 1543.16 | 2609 / 2642 | 100% | 24.86 | 704 / 705 |
kidney | 100% | 1835.48 | 89 / 89 | 94% | 16.49 | 845 / 901 |
adrenal gland | 100% | 2411.08 | 258 / 258 | 93% | 13.93 | 213 / 230 |
liver | 100% | 1290.27 | 226 / 226 | 90% | 12.28 | 366 / 406 |
adipose | 100% | 2207.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.86 | 29 / 29 |
spleen | 100% | 2291.22 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.33 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.17 | 1 / 1 |
blood vessel | 100% | 1966.29 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1833.43 | 802 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 26.99 | 78 / 80 |
heart | 97% | 1299.00 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 1940.30 | 698 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006405 | Biological process | RNA export from nucleus |
GO_0035281 | Biological process | pre-miRNA export from nucleus |
GO_0006611 | Biological process | protein export from nucleus |
GO_0010586 | Biological process | miRNA metabolic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0016442 | Cellular component | RISC complex |
GO_0042565 | Cellular component | RNA nuclear export complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1905172 | Molecular function | RISC complex binding |
GO_0000049 | Molecular function | tRNA binding |
GO_0005049 | Molecular function | nuclear export signal receptor activity |
GO_0070883 | Molecular function | pre-miRNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | XPO5 |
Protein name | Exportin-5 (Exp5) (Ran-binding protein 21) Exportin 5 |
Synonyms | RANBP21 KIAA1291 |
Description | FUNCTION: Mediates the nuclear export of proteins bearing a double-stranded RNA binding domain (dsRBD) and double-stranded RNAs (cargos). XPO5 in the nucleus binds cooperatively to the RNA and to the GTPase Ran in its active GTP-bound form. Proteins containing dsRBDs can associate with this trimeric complex through the RNA. Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause disassembly of the complex and release of the cargo from the export receptor. XPO5 then returns to the nuclear compartment by diffusion through the nuclear pore complex, to mediate another round of transport. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Overexpression may in some circumstances enhance RNA-mediated gene silencing (RNAi). Mediates nuclear export of isoform 5 of ADAR/ADAR1 in a RanGTP-dependent manner.; FUNCTION: Mediates the nuclear export of micro-RNA precursors, which form short hairpins . Also mediates the nuclear export of synthetic short hairpin RNAs used for RNA interference. In some circumstances can also mediate the nuclear export of deacylated and aminoacylated tRNAs. Specifically recognizes dsRNAs that lack a 5'-overhang in a sequence-independent manner, have only a short 3'-overhang, and that have a double-stranded length of at least 15 base-pairs . Binding is dependent on Ran-GTP . .; FUNCTION: (Microbial infection) Mediates the nuclear export of adenovirus VA1 dsRNA. . |
Accessions | ENST00000265351.12 ENST00000496341.6 H0Y3W3 H0YA57 ENST00000455285.2 Q9HAV4 ENST00000486936.2 H0Y3Q8 ENST00000398835.7 ENST00000398799.2 E2QRM3 H0Y9I3 |